Overview


According to FutureWise analysis the market for epigenetics in 2023 is US$ 2.01 billion, and is expected to reach US$ 7.73 billion by 2031 at a CAGR of 18.32%.

The availability of funds to conduct research on epigenetics, the decrease in the sequencing costs, increase in the number of patients diagnosed with cancer are some of the primary reasons accountable for the growth of the epigenetics market. There is an ongoing research pertaining to the usage of epigenetics on non-oncological diseases and with the emergence of targeted therapy, it is predicted that the market will grow remarkably owing to these factors.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Epigenetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Epigenetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Illumina
  • Thermo Fisher Scientific
  • Merck Millipore
  • Abcam
  • Active Motif
  • Bio-Rad
  • New England Biolabs
  • Agilent
  • Qiagen
  • Zymo Research
  • PerkinElmer
  • Diagenode

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Enzymes
    • DNA-modifying Enzymes
    • Protein-modifying Enzymes
    • RNA-modifying Enzymes
  • Instruments and Consumables
    • Next-generation Sequencers
    • qPCR
    • Mass Spectrometers
    • Sonicators
    • Others
  • Kits
    • Bisulfite Conversion Kits
    • ChIP-sequencing Kits
    • RNA sequencing Kits
    • Whole Genomic Amplification Kits
    • 5-hmC and 5-mC Analysis Kits
    • Others
  • Reagents
    • Antibodies
    • Buffers
    • Histones
    • Magnetic Beads
    • Primers
    • Others
  • Bioinformatics Tools

By Application

  • Oncology
  • Metabolic Diseases
  • Developmental Biology
  • Immunology
  • Cardiovascular Diseases
  • Others

By Technology

  • DNA Methylation
  • Histone Modifications
  • Others

By End User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Epigenetics Market By Product, By Application, By Technology, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Epigenetics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Epigenetics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Epigenetics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Epigenetics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enzymes
         1.1. DNA-modifying Enzymes
         1.2. Protein-modifying Enzymes
         1.3. RNA-modifying Enzymes
        2. Instruments and Consumables
         2.1. Next-generation Sequencers
         2.2. qPCR
         2.3. Mass Spectrometers
         2.4. Sonicators
         2.5. Others
        3. Kits
         3.1. Bisulfite Conversion Kits
         3.2. ChIP-sequencing Kits
         3.3. RNA sequencing Kits
         3.4. Whole Genomic Amplification Kits
         3.5. 5-hmC and 5-mC Analysis Kits
         3.6. Others
        4. Reagents
         4.1. Antibodies
         4.2. Buffers
         4.3. Histones
         4.4. Magnetic Beads
         4.5. Primers
         4.6. Others
        5. Bioinformatics

  • 8.   Global Epigenetics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oncology
        2. Metabolic Diseases
        3. Developmental Biology
        4. Immunology
        5. Cardiovascular Diseases
        6. Others

  • 9.   Global Epigenetics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. DNA Methylation
        2. Histone Modifications
        3. Others

  • 10.   Global Epigenetics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Contract Research Organizations (CROs)

  • 11.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe

  • 14.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape
    •          1. Global Landscape - Key Players, Revenue and Presence
               2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
               3. Global Emerging Companies
               4. North America - Market Share Analysis and Key Regional Players
               5. Europe - Market Share Analysis and Key Regional Players
               6. Asia Pacific - Market Share Analysis and Key Regional Players
               7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts)
    •   1. Illumina
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck Millipore
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abcam
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Active Motif
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. New England Biolabs
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Agilent
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Qiagen
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Zymo Research
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. PerkinElmer
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Diagenode
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the Medical industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the Medical regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients